Juliane Grimm

788 total citations
28 papers, 485 citations indexed

About

Juliane Grimm is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Juliane Grimm has authored 28 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 7 papers in Genetics and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Juliane Grimm's work include Acute Myeloid Leukemia Research (19 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Acute Lymphoblastic Leukemia research (6 papers). Juliane Grimm is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Acute Lymphoblastic Leukemia research (6 papers). Juliane Grimm collaborates with scholars based in Germany, United States and Norway. Juliane Grimm's co-authors include Sebastian Schwind, Madlen Jentzsch, Dietger Niederwieser, W. Zeller, Marius Bill, AR Zander, Julia Schulz, Vladan Vučinić, Georg‐Nikolaus Franke and Gerhard Behre and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cell stem cell.

In The Last Decade

Juliane Grimm

26 papers receiving 476 citations

Peers

Juliane Grimm
April Sorrell United States
Susan R. Wiersma United States
Horia Bumbea Romania
V. Shetty United States
Hyeoung Joon Kim South Korea
Catherine Garnett United Kingdom
Jeffrey Jacobsen United States
April Sorrell United States
Juliane Grimm
Citations per year, relative to Juliane Grimm Juliane Grimm (= 1×) peers April Sorrell

Countries citing papers authored by Juliane Grimm

Since Specialization
Citations

This map shows the geographic impact of Juliane Grimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliane Grimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliane Grimm more than expected).

Fields of papers citing papers by Juliane Grimm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliane Grimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliane Grimm. The network helps show where Juliane Grimm may publish in the future.

Co-authorship network of co-authors of Juliane Grimm

This figure shows the co-authorship network connecting the top 25 collaborators of Juliane Grimm. A scholar is included among the top collaborators of Juliane Grimm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliane Grimm. Juliane Grimm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwind, Sebastian, Marius Bill, Juliane Grimm, et al.. (2024). Quantifying NPM1 MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line?. HemaSphere. 8(3). e55–e55. 2 indexed citations
2.
Kao, Yun-Ruei, Jiahao Chen, Rajni Kumari, et al.. (2024). An iron rheostat controls hematopoietic stem cell fate. Cell stem cell. 31(3). 378–397.e12. 16 indexed citations
3.
Roth, Katrin, Klaus Kaier, Peter Stachon, et al.. (2023). Evolving trends in the surgical therapy of patients with endometrial cancer in Germany: analysis of a nationwide registry with special emphasis on perioperative outcomes. Archives of Gynecology and Obstetrics. 308(5). 1635–1640. 6 indexed citations
4.
Bill, Marius, Madlen Jentzsch, Jessica Kohlschmidt, et al.. (2022). Impact ofIDH1andIDH2mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation. Blood Advances. 7(3). 436–444. 22 indexed citations
5.
Grimm, Juliane, Donjetë Simnica, Nadja Jäkel, et al.. (2022). Azacitidine-induced reconstitution of the bone marrow T cell repertoire is associated with superior survival in AML patients. Blood Cancer Journal. 12(1). 19–19. 11 indexed citations
6.
Grimm, Juliane, et al.. (2021). Treatment options after a diagnosis of early miscarriage: expectant, medical, and surgical. Deutsches Ärzteblatt international. 118(46). 789–794. 10 indexed citations
7.
Grimm, Juliane, Dirk Heckl, & Jan‐Henning Klusmann. (2021). Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome. Frontiers in Oncology. 11. 636633–636633. 23 indexed citations
8.
Jentzsch, Madlen, Marius Bill, Juliane Grimm, et al.. (2020). Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML. Annals of Hematology. 99(10). 2417–2427.
9.
Jentzsch, Madlen, Juliane Grimm, Marius Bill, et al.. (2020). ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation. Bone Marrow Transplantation. 56(4). 936–945. 20 indexed citations
10.
Jentzsch, Madlen, Juliane Grimm, Marius Bill, et al.. (2020). Outcomes of Older Patients with NPM1 Mutated and FLT3‐ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation. HemaSphere. 4(1). 8 indexed citations
11.
Jentzsch, Madlen, Juliane Grimm, Vladan Vučinić, et al.. (2019). Pretreatment CD34+/CD38– Cell Burden as Prognostic Factor in Myelodysplastic Syndrome Patients Receiving Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(8). 1560–1566. 4 indexed citations
12.
Jentzsch, Madlen, Andrea Hille, Juliane Grimm, et al.. (2019). Comparison of non‐myeloablative and reduced‐intensity allogeneic stem cell transplantation in older patients with myelodysplastic syndromes. American Journal of Hematology. 94(12). 1344–1352. 8 indexed citations
13.
Bill, Marius, Juliane Grimm, Madlen Jentzsch, et al.. (2018). Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients. Annals of Hematology. 97(10). 1757–1765. 55 indexed citations
14.
Grimm, Juliane, Marius Bill, Madlen Jentzsch, et al.. (2018). Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation. Bone Marrow Transplantation. 54(8). 1189–1197. 35 indexed citations
16.
Grimm, Juliane, Madlen Jentzsch, Marius Bill, et al.. (2017). In AML RAS pathway Mutations Confer Worse Outcome in IDH1 and IDH2 Mutated AML Patients Receiving Hematopoietic Stem Cell Transplantation. Blood. 130. 2037–2037. 1 indexed citations
17.
Bill, Marius, Madlen Jentzsch, Juliane Grimm, et al.. (2017). Prognostic impact of the European LeukemiaNet standardized reporting system in older AML patients receiving stem cell transplantation after non-myeloablative conditioning. Bone Marrow Transplantation. 52(6). 932–935. 11 indexed citations
19.
Dhall, Girish, Juliane Grimm, Floyd H. Gilles, et al.. (2011). Outcome of infants and young children with newly diagnosed medulloblastoma treated on Head Start III protocol.. Journal of Clinical Oncology. 29(15_suppl). 2011–2011. 27 indexed citations
20.
Grimm, Juliane, W. Zeller, & AR Zander. (1998). Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantation as a marker for GVHD. Bone Marrow Transplantation. 21(1). 29–32. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026